The endocannabinoid system regulates a broad range of psychological and physiological processes throughout the body, and its dysregulation has been implicated in numerous pathological conditions. As a result, components of this system are common targets in diagnostic and therapeutic research. Given the challenges associated with obtaining tissue samples from human participants, current research commonly relies on the quantification of circulating endocannabinoids in blood as a surrogate for tissue-level endocannabinoid activity. However, this approach presents limitations due to the invasive nature of blood collection and its potential to induce pain or stress-related activation of the endocannabinoid system. New methods to study the activity of the endocannabinoid system in humans are therefore needed.
Methods:
This narrative review examines the current literature investigating the measurement, origin, and significance of the endocannabinoid ligands N-arachidonoylethanolamide (AEA) and 2-arachidonoylglycerol (2-AG) in human saliva, a non-invasive and easily accessible biological matrix.
Results:
Mass spectromic analysis have demonstrated that AEA and 2-AG levels are dynamic and can be influenced by physiological challenges, including fear, stress, and exercise. Salivary endocannabinoid profiles have also been shown to reflect longer-term traits, such as metabolic status, and can distinguish between patients and healthy individuals in conditions like orofacial pain.
Discussion:
Collectively, salivary endocannabinoids reflect both acute and chronic aspects of endocannabinoid system activity and may represent a promising non-invasive matrix for assessing endocannabinoid function. However, further understanding of the mechanisms underlying endocannabinoid production in the oral cavity is required for accurate interpretation of salivary measurements in future studies.
DevaneWA, HanusL, BreuerA, et al.Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science, 1992; 258(5090):1946–1949; doi: 10.1126/science.1470919
2.
SugiuraT, KondoS, SukagawaA, et al.2-Arachidonoylglycerol: A possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun, 1995; 215(1):89–97; doi: 10.1006/bbrc.1995.2437
3.
MatsudaLA, LolaitSJ, BrownsteinMJ, et al.Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature, 1990; 346(6284):561–564; doi: 10.1038/346561a0
4.
MunroS, ThomasKL, Abu-ShaarM. Molecular characterization of a peripheral receptor for cannabinoids. Nature, 1993; 365(6441):61–65; doi: 10.1038/365061a0
5.
SchmidPC, ReddyPV, NatarajanV, et al.Metabolism of N-acylethanolamine phospholipids by a mammalian phosphodiesterase of the phospholipase D type. J Biol Chem, 1983; 258(15):9302–9306.
6.
CravattBF, LichtmanAH. Fatty acid amide hydrolase: An emerging therapeutic target in the endocannabinoid system. Curr Opin Chem Biol, 2003; 7(4):469–475; doi: 10.1016/S1367-5931(03)00079-6
7.
BisognoT, HowellF, WilliamsG, et al.Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J Cell Biol, 2003; 163(3):463–468; doi: 10.1083/jcb.200305129
8.
BlankmanJL, SimonGM, CravattBF. A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chem Biol, 2007; 14(12):1347–1356; doi: 10.1016/j.chembiol.2007.11.006
9.
FowlerCJ. The contribution of cyclooxygenase-2 to endocannabinoid metabolism and action. Br J Pharmacol, 2007; 152(5):594–601; doi: 10.1038/sj.bjp.0707379
10.
HoWS, BarrettDA, RandallMD. ‘Entourage’ effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors. Br J Pharmacol, 2008; 155(6):837–846; doi: 10.1038/bjp.2008.324
11.
CastilloPE, YountsTJ, ChávezAE, et al.Endocannabinoid signaling and synaptic function. Neuron, 2012; 76(1):70–81; doi: 10.1016/j.neuron.2012.09.020
12.
LutzB. Endocannabinoid signals in the control of emotion. Curr Opin Pharmacol, 2009; 9(1):46–52; doi: 10.1016/j.coph.2008.12.001
13.
MarsicanoG, LafenêtreP. Roles of the endocannabinoid system in learning and memory. Curr Top Behav Neurosci, 2009; 1:201–230; doi: 10.1007/978-3-540-88955-7_8
14.
NeyLJ, CrombieKM, MayoLM. Chapter 5 - The endocannabinoid system and posttraumatic stress disorder (PTSD): A new narrative. In: Neurobiology and Physiology of the Endocannabinoid System. (PatelVB, PreedyVR, MartinCR., eds.) Academic Press; 2023; pp. 67–79.
15.
SpanagelR. Cannabinoids and the endocannabinoid system in reward processing and addiction: From mechanisms to interventions. Dialogues Clin Neurosci, 2020; 22(3):241–250; doi: 10.31887/DCNS.2020.22.3/rspanagel
16.
TadijanA, VlašićI, VlainićJ, et al.Intracellular molecular targets and signaling pathways involved in antioxidative and neuroprotective effects of cannabinoids in neurodegenerative conditions. Antioxidants (Basel), 2022; 11(10):2049; doi: 10.3390/antiox11102049
17.
MaccarroneM, BabI, BíróT, et al.Endocannabinoid signaling at the periphery: 50 years after THC. Trends Pharmacol Sci, 2015; 36(5):277–296; doi: 10.1016/j.tips.2015.02.008
18.
MatiasI, Di MarzoV. Endocannabinoids and the control of energy balance. Trends Endocrinol Metab, 2007; 18(1):27–37; doi: 10.1016/j.tem.2006.11.006
19.
GuindonJ, HohmannAG. The endocannabinoid system and pain. CNS Neurol Disord Drug Targets, 2009; 8(6):403–421; doi: 10.2174/187152709789824660
20.
RahamanO, GangulyD. Endocannabinoids in immune regulation and immunopathologies. Immunology, 2021; 164(2):242–252; doi: 10.1111/imm.13378
21.
HillardCJ, BeatkaM, SarvaideoJ. Endocannabinoid signaling and the hypothalamic-pituitary-adrenal axis. Compr Physiol, 2016; 7(1):1–15; doi: 10.1002/cphy.c160005
22.
HillMN, TaskerJG. Endocannabinoid signaling, glucocorticoid-mediated negative feedback, and regulation of the hypothalamic-pituitary-adrenal axis. Neuroscience, 2012; 204:5–16; doi: 10.1016/j.neuroscience.2011.12.030
23.
MorenaM, PatelS, BainsJS, et al.Neurobiological interactions between stress and the endocannabinoid system. Neuropsychopharmacology, 2016; 41(1):80–102; doi: 10.1038/npp.2015.166
24.
D’AngeloM, SteardoLJr. Cannabinoids and sleep: Exploring biological mechanisms and therapeutic potentials. Int J Mol Sci, 2024; 25(7):3603; doi: 10.3390/ijms25073603
25.
HileyCR. Endocannabinoids and the heart. J Cardiovasc Pharmacol, 2009; 53(4):267–276; doi: 10.1097/FJC.0b013e318192671d
26.
KaczochaM, Haj-DahmaneS. Mechanisms of endocannabinoid transport in the brain. Br J Pharmacol, 2022; 179(17):4300–4310; doi: 10.1111/bph.15469
27.
NeyLJ, FelminghamKL, BrunoR, et al.Chloroform-based liquid-liquid extraction and LC-MS/MS quantification of endocannabinoids, cortisol and progesterone in human hair. J Pharm Biomed Anal, 2021; 201:114103; doi: 10.1016/j.jpba.2021.114103
28.
KantaeV, OginoS, NogaM, et al.Quantitative profiling of endocannabinoids and related N-acylethanolamines in human CSF using nano LC-MS/MS. J Lipid Res, 2017; 58(3):615–624; doi: 10.1194/jlr.D070433
29.
HillardCJ. Circulating endocannabinoids: From whence do they come and where are they going? Neuropsychopharmacology, 2018; 43(1):155–172; doi: 10.1038/npp.2017.130
30.
CrombieKM, LeitzelarBN, BrellenthinAG, et al.Loss of exercise- and stress-induced increases in circulating 2-arachidonoylglycerol concentrations in adults with chronic PTSD. Biol Psychol, 2019; 145:1–7; doi: 10.1016/j.biopsycho.2019.04.002
31.
NeyLJ. Understanding the role of endocannabinoids in posttraumatic stress disorder. Int J Mol Sci, 2025; 26(12):5527.
32.
AltamuraC, VentrigliaM, MartiniMG, et al.Elevation of plasma 2-arachidonoylglycerol levels in Alzheimer’s disease patients as a potential protective mechanism against neurodegenerative decline. J Alzheimers Dis, 2015; 46(2):497–506; doi: 10.3233/jad-142349
33.
Martín GiménezVM, NoriegaSE, KassuhaDE, et al.Anandamide and endocannabinoid system: An attractive therapeutic approach for cardiovascular disease. Ther Adv Cardiovasc Dis, 2018; 12(7):177–190; doi: 10.1177/1753944718773690
34.
La PortaC, BuraSA, Llorente-OnaindiaJ, et al.Role of the endocannabinoid system in the emotional manifestations of osteoarthritis pain. Pain, 2015; 156(10):2001–2012; doi: 10.1097/j.pain.0000000000000260
35.
GowatchLC, EvanskiJM, ElySL, et al.Endocannabinoids and stress-related neurospsychiatric disorders: A systematic review and meta-analysis of basal concentrations and response to acute psychosocial stress. Cannabis Cannabinoid Res, 2024; 9(5):1217–1234; doi: 10.1089/can.2023.0246
36.
WoodhamsSG, SagarDR, BurstonJJ, et al.The role of the endocannabinoid system in pain. In: Pain Control. (SchaibleH-G, eds.) Springer Berlin Heidelberg: Berlin, Heidelberg; 2015; pp. 119–143.
37.
WeckesserLJ, PlessowF, PilhatschM, et al.Do venepuncture procedures induce cortisol responses? A review, study, and synthesis for stress research. Psychoneuroendocrinology, 2014; 46:88–99; doi: 10.1016/j.psyneuen.2014.04.012
38.
NeyLJ, FelminghamKL, BrunoR, et al.Simultaneous quantification of endocannabinoids, oleoylethanolamide and steroid hormones in human plasma and saliva. J Chromatogr B Analyt Technol Biomed Life Sci, 2020; 1152:122252; doi: 10.1016/j.jchromb.2020.122252
39.
MatiasI, Gatta-CherifiB, TabarinA, et al.Endocannabinoids measurement in human saliva as potential biomarker of obesity. PLoS One, 2012; 7(7):e42399; doi: 10.1371/journal.pone.0042399
40.
YoshizawaJM, SchaferCA, SchaferJJ, et al.Salivary biomarkers: Toward future clinical and diagnostic utilities. Clin Microbiol Rev, 2013; 26(4):781–791; doi: 10.1128/cmr.00021-13
41.
ViningRF, McGinleyRA, MaksvytisJJ, et al.Salivary cortisol: A better measure of adrenal cortical function than serum cortisol. Ann Clin Biochem, 1983; 20 (Pt 6)(Pt 6):329–335; doi: 10.1177/000456328302000601
42.
NaterUM, RohlederN. Salivary alpha-amylase as a non-invasive biomarker for the sympathetic nervous system: Current state of research. Psychoneuroendocrinology, 2009; 34(4):486–496; doi: 10.1016/j.psyneuen.2009.01.014
43.
NeyLJ, StoneC, NicholsD, et al.Endocannabinoid reactivity to acute stress: Investigation of the relationship between salivary and plasma levels. Biol Psychol, 2021; 159:108022; doi: 10.1016/j.biopsycho.2021.108022
44.
KratzD, SensA, SchäferSMG, et al.Pre-analytical challenges for the quantification of endocannabinoids in human serum. J Chromatogr B Analyt Technol Biomed Life Sci, 2022; 1190:123102; doi: 10.1016/j.jchromb.2022.123102
45.
KratzD, ThomasD, GurkeR. Endocannabinoids as potential biomarkers: It’s all about pre-analytics. J Mass Spectrom Adv Clin Lab, 2021; 22:56–63; doi: 10.1016/j.jmsacl.2021.11.001
46.
FrancescaB, TommasoL, PietroS, et al.Saliva sampling: Methods and devices. An overview. TrAC Trends in Analytical Chemistry, 2020; 124:115781.
47.
FigueiraJ, Gouveia-FigueiraS, ÖhmanC, et al.Metabolite quantification by NMR and LC-MS/MS reveals differences between unstimulated, stimulated, and pure parotid saliva. J Pharm Biomed Anal, 2017; 140:295–300; doi: 10.1016/j.jpba.2017.03.037
48.
De LucaL, FerracaneR, Calderón RamírezN, et al.N-Acylphosphatidylethanolamines and N-acylethanolamines increase in saliva upon food mastication: The influence of the individual nutritional status and fat type in food. Food Funct, 2020; 11(4):3382–3392; doi: 10.1039/c9fo02205h
49.
HavivY, GeorgievO, Gaver-BrachaT, et al.Reduced endocannabinoid tone in saliva of chronic orofacial pain patients. Molecules, 2022; 27(14):4662; doi: 10.3390/molecules27144662
50.
MennellaI, Di MonacoR, BalazyA, et al.Salivary endocannabinoids and N-acylethanolamines upon mastication of a semisolid food: Implications in fat taste, appetite and food liking. Food Funct, 2018; 9(1):476–484; doi: 10.1039/c7fo01772c
51.
TintoF, ArchambaultAS, DumaisÉ, et al.Synthesis and molecular targets of N-13-hydroxy-octadienoyl-ethanolamine, a novel endogenous bioactive 15-lipoxygenase-derived metabolite of N-linoleoyl-ethanolamine found in the skin and saliva. Biochim Biophys Acta Mol Cell Biol Lipids, 2021; 1866(8):158954; doi: 10.1016/j.bbalip.2021.158954
52.
WuY, WuY, DengJ, et al.Screening and identification of salivary biomarkers for assessing the effects of exogenous testosterone administration on HPG and HPA axes and ECS. Steroids, 2020; 158:108604; doi: 10.1016/j.steroids.2020.108604
53.
JarvisM, HamzahKA, NicholsD, et al.Hair and saliva endocannabinoid and steroid hormone analysis by liquid chromatography paired with tandem mass spectrometry. Methods Mol Biol, 2025; 2868:135–147; doi: 10.1007/978-1-0716-4200-9_8
54.
KongX, FerracaneR, De LucaL, et al.Salivary concentration of N-acylethanolamines upon food mastication and after meal consumption: Influence of food dietary fiber. Food Res Int, 2016; 89(Pt 1):186–193; doi: 10.1016/j.foodres.2016.07.026
55.
Amir HamzahK, TurnerN, NicholsD, et al.Advances in targeted liquid chromatography-tandem mass spectrometry methods for endocannabinoid and N-acylethanolamine quantification in biological matrices: A systematic review. Mass Spectrom Rev, 2025; 44(3):513–538; doi: 10.1002/mas.21897
56.
ZoernerAA, GutzkiFM, BatkaiS, et al.Quantification of endocannabinoids in biological systems by chromatography and mass spectrometry: A comprehensive review from an analytical and biological perspective. Biochim Biophys Acta, 2011; 1811(11):706–723; doi: 10.1016/j.bbalip.2011.08.004
57.
HargreavesJ, NeyLJ. Experimental and pre-analytical considerations of endocannabinoid quantification in human biofluids prior to mass spectrometric analysis. Targets, 2025; 3(1):11.
58.
VogeserM, HauerD, Christina AzadS, et al.Release of anandamide from blood cells. Clin Chem Lab Med, 2006; 44(4):488–491; doi: 10.1515/cclm.2006.065
59.
FowlerCJ. Transport of endocannabinoids across the plasma membrane and within the cell. Febs J, 2013; 280(9):1895–1904; doi: 10.1111/febs.12212
60.
MeierP, GlasmacherS, SalmenA, et al.Comparative targeted lipidomics between serum and cerebrospinal fluid of multiple sclerosis patients shows sex and age-specific differences of endocannabinoids and glucocorticoids. Acta Neuropathol Commun, 2024; 12(1):160; doi: 10.1186/s40478-024-01864-2
61.
Valdivieso BarbaS, KirschbaumC, GaoW. Endocannabinoid and perceived stress: Association analysis of endocannabinoid levels in hair versus levels in plasma and urine. Biol Psychol, 2023; 178:108541; doi: 10.1016/j.biopsycho.2023.108541
62.
NeyLJ, CooperJ, LamGN, et al.Hair endocannabinoids predict physiological fear conditioning and salivary endocannabinoids predict subjective stress reactivity in humans. Psychoneuroendocrinology, 2023; 154:106296; doi: 10.1016/j.psyneuen.2023.106296
63.
HowlettAC, ReggioPH, ChildersSR, et al.Endocannabinoid tone versus constitutive activity of cannabinoid receptors. Br J Pharmacol, 2011; 163(7):1329–1343; doi: 10.1111/j.1476-5381.2011.01364.x
TaraborrelliS. Physiology, production and action of progesterone. Acta Obstet Gynecol Scand, 2015; 94 Suppl 161:8–16; doi: 10.1111/aogs.12771
66.
WoodP. Salivary steroid assays - Research or routine? Ann Clin Biochem, 2009; 46(Pt 3):183–196; doi: 10.1258/acb.2008.008208
67.
de PaulaF, TeshimaTHN, HsiehR, et al.Overview of human salivary glands: Highlights of morphology and developing processes. Anat Rec (Hoboken), 2017; 300(7):1180–1188; doi: 10.1002/ar.23569
PrestifilippoJP, Fernández-SolariJ, MedinaV, et al.Role of the endocannabinoid system in ethanol-induced inhibition of salivary secretion. Alcohol Alcohol, 2009; 44(5):443–448; doi: 10.1093/alcalc/agp040
70.
TurnerRJ, SugiyaH. Understanding salivary fluid and protein secretion. Oral Dis, 2002; 8(1):3–11; doi: 10.1034/j.1601-0825.2002.10815.x
71.
ProctorGB. The physiology of salivary secretion. Periodontol 2000, 2016; 70(1):11–25; doi: 10.1111/prd.12116
72.
BuschL, Sterin-BordaL, BordaE. Expression and biological effects of CB1 cannabinoid receptor in rat parotid gland. Biochem Pharmacol, 2004; 68(9):1767–1774; doi: 10.1016/j.bcp.2004.06.029
73.
PrestifilippoJP, Fernández-SolariJ, de la CalC, et al.Inhibition of salivary secretion by activation of cannabinoid receptors. Exp Biol Med (Maywood), 2006; 231(8):1421–1429; doi: 10.1177/153537020623100816
74.
KopachO, VatsJ, NetsykO, et al.Cannabinoid receptors in submandibular acinar cells: Functional coupling between saliva fluid and electrolytes secretion and Ca2+ signalling. J Cell Sci, 2012; 125(Pt 8):1884–1895; doi: 10.1242/jcs.088930
75.
Fernandez-SolariJ, PrestifilippoJP, OssolaCA, et al.Participation of the endocannabinoid system in lipopolysaccharide-induced inhibition of salivary secretion. Arch Oral Biol, 2010; 55(8):583–590; doi: 10.1016/j.archoralbio.2010.05.006
76.
Fernandez-SolariJ, PrestifilippoJP, VissioP, et al.Anandamide injected into the lateral ventricle of the brain inhibits submandibular salivary secretion by attenuating parasympathetic neurotransmission. Braz J Med Biol Res, 2009; 42(6):537–544; doi: 10.1590/s0100-879x2009000600010
77.
Dall’AglioC, MercatiF, PascucciL, et al.Immunohistochemical localization of CB1 receptor in canine salivary glands. Vet Res Commun, 2010; 34 Suppl 1:S9–S12; doi: 10.1007/s11259-010-9379-0
78.
MurataevaN, MattoxS, LemieuxJ, et al.Cannabinoid regulation of sex-dependent murine odorant-stimulated salivation. Sci Rep, 2024; 14(1):26720; doi: 10.1038/s41598-024-77761-4
79.
CarvalhoAF, Van BockstaeleEJ. Cannabinoid modulation of noradrenergic circuits: Implications for psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry, 2012; 38(1):59–67; doi: 10.1016/j.pnpbp.2012.01.008
80.
Gallego-LandinI, García-BaosA, Castro-ZavalaA, et al.Reviewing the role of the endocannabinoid system in the pathophysiology of depression. Front Pharmacol, 2021; 12:762738; doi: 10.3389/fphar.2021.762738
81.
ThoungseabyounW, TachowA, PakkaratoS, et al.Immunohistochemical localization of cannabinoid receptor 1 (CB1) in the submandibular gland of mice under normal conditions and when stimulated by isoproterenol or carbachol. Arch Oral Biol, 2017; 81:160–166; doi: 10.1016/j.archoralbio.2017.05.003
82.
HuZ, QinZ, XieJ, et al.Cannabidiol and its application in the treatment of oral diseases: Therapeutic potentials, routes of administration and prospects. Biomed Pharmacother, 2024; 176:116271; doi: 10.1016/j.biopha.2024.116271
83.
BorsaniE, MajoranaA, CocchiMA, et al.Epithelial expression of vanilloid and cannabinoid receptors: A potential role in burning mouth syndrome pathogenesis. Histol Histopathol, 2014; 29(4):523–533; doi: 10.14670/hh-29.10.523
84.
JyotakiM, ShigemuraN, NinomiyaY. Modulation of sweet taste sensitivity by orexigenic and anorexigenic factors. Endocr J, 2010; 57(6):467–475; doi: 10.1507/endocrj.k10e-095
85.
QueK, HeD, JinY, et al.Expression of cannabinoid type 1 receptors in human odontoblast cells. J Endod, 2017; 43(2):283–288; doi: 10.1016/j.joen.2016.10.004
86.
GodoyLD, RossignoliMT, Delfino-PereiraP, et al.A comprehensive overview on stress neurobiology: Basic concepts and clinical implications. Front Behav Neurosci, 2018; 12:127; doi: 10.3389/fnbeh.2018.00127
87.
O’DonohueMP, Amir HamzahK, NicholsD, et al.Trauma film viewing and intrusive memories: Relationship between salivary alpha amylase, endocannabinoids, and cortisol. Psychoneuroendocrinology, 2024; 164:107007; doi: 10.1016/j.psyneuen.2024.107007
88.
NaterUM, La MarcaR, FlorinL, et al.Stress-induced changes in human salivary alpha-amylase activity—Associations with adrenergic activity. Psychoneuroendocrinology, 2006; 31(1):49–58; doi: 10.1016/j.psyneuen.2005.05.010
89.
BoschJA, VeermanEC, de GeusEJ, et al.α-Amylase as a reliable and convenient measure of sympathetic activity: Don’t start salivating just yet!. Psychoneuroendocrinology, 2011; 36(4):449–453; doi: 10.1016/j.psyneuen.2010.12.019
90.
JamesEL, Lau-ZhuA, ClarkIA, et al.The trauma film paradigm as an experimental psychopathology model of psychological trauma: Intrusive memories and beyond. Clin Psychol Rev, 2016; 47:106–142; doi: 10.1016/j.cpr.2016.04.010
91.
TarragonE, BindilaL, ZimmerP, et al.Salivary endocannabinoids as mediators in the relationship between omega-6 and omega-3 fatty acid ratio intake from highly-processed foods and anthropometric markers of health in women. Int J Food Sci Nutr, 2020; 71(2):235–241; doi: 10.1080/09637486.2019.1632274
92.
FloresA, MaldonadoR, BerrenderoF. Cannabinoid-hypocretin cross-talk in the central nervous system: What we know so far. Front Neurosci, 2013; 7:256; doi: 10.3389/fnins.2013.00256
93.
KibretBG, Canseco-AlbaA, OnaiviES, et al.Crosstalk between the endocannabinoid and mid-brain dopaminergic systems: Implication in dopamine dysregulation. Front Behav Neurosci, 2023; 17:1137957; doi: 10.3389/fnbeh.2023.1137957
94.
MeccarielloR. Endocannabinoid system in health and disease: Current situation and future perspectives. Int J Mol Sci, 2020; 21(10):3549; doi: 10.3390/ijms21103549
95.
HeiliczerS, WilenskyA, GaverT, et al.Salivary endocannabinoid profiles in chronic orofacial pain and headache disorders: An observational study using a novel tool for diagnosis and management. Int J Mol Sci, 2022; 23(21):13017; doi: 10.3390/ijms232113017
96.
PrestifilippoJP, MedinaVA, MohnCE, et al.Endocannabinoids mediate hyposalivation induced by inflammogens in the submandibular glands and hypothalamus. Arch Oral Biol, 2013; 58(9):1251–1259; doi: 10.1016/j.archoralbio.2013.04.003
97.
FurmanD, CampisiJ, VerdinE, et al.Chronic inflammation in the Etiology of disease across the life span. Nat Med, 2019; 25(12):1822–1832; doi: 10.1038/s41591-019-0675-0
98.
Amir HamzahK, TomsLM, KucharskiN, et al.Sex-dimorphism in human serum endocannabinoid and n-acyl ethanolamine concentrations across the lifespan. Sci Rep, 2023; 13(1):23059; doi: 10.1038/s41598-023-50426-4
99.
HargreavesJ, JarvisM, Amir HamzahK, et al.Stress responsivity of endocannabinoids and related biomolecules in plasma and saliva. Cannabis Cannabinoid Res, 2025; doi: 10.1177/25785125251387514
100.
NidadavoluP, Bilkei-GorzoA, EffahF, et al.Dynamic changes in the endocannabinoid system during the aging process: Focus on the middle-age crisis. Int J Mol Sci, 2022; 23(18):10254; doi: 10.3390/ijms231810254
101.
DallabridaKG, de Oliveira BenderJM, ChadeES, et al.Endocannabinoid system changes throughout life: Implications and therapeutic potential for autism, ADHD, and Alzheimer’s disease. Brain Sci, 2024; 14(6):592; doi: 10.3390/brainsci14060592
102.
HellhammerDH, WüstS, KudielkaBM. Salivary cortisol as a biomarker in stress research. Psychoneuroendocrinology, 2009; 34(2):163–171; doi: 10.1016/j.psyneuen.2008.10.026
103.
CliftonS, MacdowallW, CopasAJ, et al.Salivary testosterone levels and health status in men and women in the British general population: Findings from the third national survey of sexual attitudes and lifestyles (Natsal-3). J Clin Endocrinol Metab, 2016; 101(11):3939–3951; doi: 10.1210/jc.2016-1669
104.
HuangT, HowseFM, StachenfeldNS, et al.Correlations between salivary- and blood-derived gonadal hormone assessments and implications for inclusion of female participants in research studies. Am J Physiol Heart Circ Physiol, 2023; 324(1):H33–H46; doi: 10.1152/ajpheart.00399.2022
105.
DziurkowskaE, WesolowskiM. Cortisol as a biomarker of mental disorder severity. J Clin Med, 2021; 10(21):5204; doi: 10.3390/jcm10215204
106.
YuanN, ChenY, XiaY, et al.Inflammation-related biomarkers in major psychiatric disorders: A cross-disorder assessment of reproducibility and specificity in 43 meta-analyses. Transl Psychiatry, 2019; 9(1):233; doi: 10.1038/s41398-019-0570-y
107.
HicksSD, JacobP, PerezO, et al.The transcriptional signature of a runner’s high. Med Sci Sports Exerc, 2019; 51(5):970–978; doi: 10.1249/mss.0000000000001865
108.
Di BartolomeoM, ČerňanováA, PetrušováV, et al.DNA methylation at cannabinoid type 1 and dopamine D2 receptor genes in saliva samples of psychotic subjects: Is there an effect of cannabis use? Pharmacol Res, 2024; 208:107343; doi: 10.1016/j.phrs.2024.107343
109.
BlairJ, AdawayJ, KeevilB, et al.Salivary cortisol and cortisone in the clinical setting. Curr Opin Endocrinol Diabetes Obes, 2017; 24(3):161–168; doi: 10.1097/med.0000000000000328
110.
NelsonJ, ManzellaK, BakerOJ. Current cell models for bioengineering a salivary gland: A mini-review of emerging technologies. Oral Dis, 2013; 19(3):236–244; doi: 10.1111/j.1601-0825.2012.01958.x
111.
StrahlerJ, SkoludaN, KappertMB, et al.Simultaneous measurement of salivary cortisol and alpha-amylase: Application and recommendations. Neurosci Biobehav Rev, 2017; 83:657–677; doi: 10.1016/j.neubiorev.2017.08.015
